Respiri Ltd Market Cap ($39.01 Million)
Market Cap & Net Worth: Respiri Ltd (RSH)
Respiri Ltd market cap. Respiri Ltd (AU:RSH) has a market capitalization of $39.01 Million (AU$55.13 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #22557 globally and #803 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Respiri Ltd's stock price AU$0.04 by its total outstanding shares 1575280000 (1.58 Billion). Also see Respiri Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Respiri Ltd Market Cap History (2015–2025)
Respiri Ltd market cap history from 2015 to 2025. Data shows change from $44.70 Million to $39.01 Million (-5.20% CAGR). Check Respiri Ltd share price for real-time trading data and today's change.
Respiri Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Respiri Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Respiri Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
202.47x
Respiri Ltd's market cap is 202.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $44.70 Million | $93.99K | -$5.46 Million | 475.55x | N/A |
| 2016 | $46.81 Million | $677.75K | -$4.01 Million | 69.07x | N/A |
| 2017 | $49.04 Million | $825.60K | -$2.52 Million | 59.40x | N/A |
| 2018 | $105.89 Million | $861.46K | -$3.21 Million | 122.92x | N/A |
| 2019 | $107.00 Million | $1.03 Million | -$8.47 Million | 104.27x | N/A |
| 2020 | $144.90 Million | $2.16 Million | -$7.26 Million | 67.23x | N/A |
| 2021 | $71.34 Million | $270.07K | -$11.04 Million | 264.13x | N/A |
| 2022 | $51.27 Million | $253.69K | -$6.62 Million | 202.11x | N/A |
| 2023 | $33.44 Million | $70.53K | -$5.78 Million | 474.08x | N/A |
| 2024 | $92.51 Million | $456.91K | -$7.13 Million | 202.47x | N/A |
Competitor Companies of RSH by Market Capitalization
Companies near Respiri Ltd in the global market cap rankings as of November 8, 2026. Also see Respiri Ltd (RSH) total assets for a full breakdown of the balance sheet.
Key companies related to Respiri Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Respiri Ltd (2015–2025)
Market capitalization of Respiri Ltd from 2015 to today. Between 2015 and today, Respiri Ltd's market cap moved from $44.70 Million to $ 39.01 Million, with a yearly change of -5.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$39.01 Million | -57.83% |
| 2024 | AU$92.51 Million | +176.67% |
| 2023 | AU$33.44 Million | -34.78% |
| 2022 | AU$51.27 Million | -28.12% |
| 2021 | AU$71.34 Million | -50.77% |
| 2020 | AU$144.90 Million | +35.42% |
| 2019 | AU$107.00 Million | +1.05% |
| 2018 | AU$105.89 Million | +115.91% |
| 2017 | AU$49.04 Million | +4.76% |
| 2016 | AU$46.81 Million | +4.74% |
| 2015 | AU$44.70 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 24th, 2026 the market cap of Respiri Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.01 Million USD |
| MoneyControl | $39.01 Million USD |
| MarketWatch | $39.01 Million USD |
| marketcap.company | $39.01 Million USD |
| Reuters | $39.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Respiri Ltd
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limi… Read more